JP2001515713A5 - - Google Patents

Download PDF

Info

Publication number
JP2001515713A5
JP2001515713A5 JP2000510843A JP2000510843A JP2001515713A5 JP 2001515713 A5 JP2001515713 A5 JP 2001515713A5 JP 2000510843 A JP2000510843 A JP 2000510843A JP 2000510843 A JP2000510843 A JP 2000510843A JP 2001515713 A5 JP2001515713 A5 JP 2001515713A5
Authority
JP
Japan
Prior art keywords
monocyte
cells
lesion
derived
site
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2000510843A
Other languages
English (en)
Japanese (ja)
Other versions
JP2001515713A (ja
Filing date
Publication date
Priority claimed from US08/924,830 external-priority patent/US20020068048A1/en
Application filed filed Critical
Publication of JP2001515713A publication Critical patent/JP2001515713A/ja
Publication of JP2001515713A5 publication Critical patent/JP2001515713A5/ja
Pending legal-status Critical Current

Links

JP2000510843A 1997-09-05 1998-08-31 散在性の若しくはアクセス困難な細胞又は組織を有するヒト病状の処置又は診断方法 Pending JP2001515713A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US08/924,830 1997-09-05
US08/924,830 US20020068048A1 (en) 1997-09-05 1997-09-05 Method for the treatment or diagnosis of human pathologies with disseminated or difficult to access cells or tissues
PCT/EP1998/005707 WO1999013054A2 (en) 1997-09-05 1998-08-31 Method for the treatment or diagnosis of human pathologies with disseminated or difficult to access cells or tissues

Publications (2)

Publication Number Publication Date
JP2001515713A JP2001515713A (ja) 2001-09-25
JP2001515713A5 true JP2001515713A5 (cg-RX-API-DMAC10.html) 2006-01-05

Family

ID=25450795

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2000510843A Pending JP2001515713A (ja) 1997-09-05 1998-08-31 散在性の若しくはアクセス困難な細胞又は組織を有するヒト病状の処置又は診断方法

Country Status (7)

Country Link
US (2) US20020068048A1 (cg-RX-API-DMAC10.html)
EP (1) EP1009806A2 (cg-RX-API-DMAC10.html)
JP (1) JP2001515713A (cg-RX-API-DMAC10.html)
AU (1) AU752676B2 (cg-RX-API-DMAC10.html)
CA (1) CA2300387A1 (cg-RX-API-DMAC10.html)
IL (1) IL134393A0 (cg-RX-API-DMAC10.html)
WO (1) WO1999013054A2 (cg-RX-API-DMAC10.html)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000060054A1 (en) * 1999-04-06 2000-10-12 MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. Pharmaceutical compositions comprising circulating blood cells, preferably monocytes and uses thereof
AU1375301A (en) * 1999-11-15 2001-05-30 Bio Syntech Canada Inc Temperature-controlled and ph-dependant self-gelling biopolymeric aqueous solution
AU5159901A (en) * 2000-04-14 2001-10-30 Univ Pittsburgh Soft tissue and bone augmentation and bulking utilizing muscle-derived progenitor cells, compositions and treatments thereof
EP1335687B1 (en) * 2000-11-15 2007-01-10 Bio Syntech Canada Inc. Method for restoring a damaged or degenerated intervertebral disc
KR101114784B1 (ko) 2002-11-12 2012-02-27 예일 유니버시티 아데노바이러스 벡터 백신
ATE482713T1 (de) * 2003-04-25 2010-10-15 Univ Pittsburgh Von muskeln stammende zellen (mdcs) zur förderung und verbesserung der nervenreparatur und - regeneration
US8986736B2 (en) 2003-06-24 2015-03-24 Baxter International Inc. Method for delivering particulate drugs to tissues
US9044381B2 (en) 2003-06-24 2015-06-02 Baxter International Inc. Method for delivering drugs to the brain
RU2006144851A (ru) 2004-06-15 2008-06-20 Бакстер Интернэшнл Инк. (Us) Применение терапевтических средств ex-vivo в виде твердых микрочастиц
US20100178355A1 (en) * 2006-11-30 2010-07-15 Hoemann Caroline D Method for in situ solidification of blood-polymer compositions for regenerative medicine and cartilage repair applications
RU2496482C2 (ru) 2008-03-05 2013-10-27 Бакстер Интернэшнл Инк. Композиции и способы для доставки лекарственных средств
EP2328596B1 (en) * 2008-08-18 2019-03-06 University of Pittsburgh - Of the Commonwealth System of Higher Education Bone augmentation utilizing muscle-derived progenitor compositions in biocompatible matrix, and treatments thereof
US10952965B2 (en) 2009-05-15 2021-03-23 Baxter International Inc. Compositions and methods for drug delivery
GB201504251D0 (en) 2015-03-13 2015-04-29 Virttu Biolog Ltd And University Of Sheffield The Oncolytic herpes simplex virus infected cells

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2709309B1 (fr) * 1993-08-25 1995-11-10 Centre Nat Rech Scient Compositions cellulaires, préparation et utilisations thérapeutiques.
FR2729570A1 (fr) * 1995-01-24 1996-07-26 Idm Immuno Designed Molecules Procede de preparation de macrophages actives, trousses et compositions pour la mise en oeuvre de ce procede

Similar Documents

Publication Publication Date Title
CN102741405B (zh) 提高基因表达的系统和保持有该系统的载体
EP0707071B1 (en) Recombinant vectors derived from adenovirus for use in gene therapy
US20160250290A1 (en) Gene therapy for diabetic ischemic disease
AU704910B2 (en) Recombinant adenoviruses encoding glial cell neurotrophic factor (GDNF)
CN102886052A (zh) 长效药物制剂
Bankiewicz et al. Practical Aspects of the Development ofex Vivoandin VivoGene Therapy for Parkinson's Disease
DE69432500T2 (de) Rekombinante Foamy-Virus-Vektoren zur medizinischen und diagnostischen Verwendung und Verfahren zur Herstellung rekombinanter Foamy-Virus-Vektoren
CA3106261A1 (en) Methods of treating non-syndromic sensorineural hearing loss
AU752676B2 (en) Method for the treatment or diagnosis of human pathologies with disseminated or difficult to access cells or tissues
JP2005504010A (ja) 成長ホルモンおよびfoxm1bを用いた肝臓疾患および肝臓損傷の処置方法
CN112567053A (zh) 重组核酸构建体
US6613319B2 (en) Long-term expression of erythropoietin and growth hormone by transforming muscle cells
JP2001270840A (ja) 免疫疾患の治療
US20250179450A1 (en) CRISPR/SpCas9 VARIANT AND METHODS FOR ENHANCED CORRECTION OF DUCHENNE MUSCULAR DYSTROPHY MUTATIONS
JP3410738B2 (ja) ミクログリアからなる医薬用キャリアー
JP2024533396A5 (cg-RX-API-DMAC10.html)
US20020155421A1 (en) Endothelial cell mitogen bioassay
EP4636093A1 (en) Targeting mapk-erk pathway for enhancing nucleic acid delivery
JP2003500336A (ja) (自己)免疫疾患の治療におけるアポトーシス誘発剤の使用
DE19929104A1 (de) Neue Vektorkomplexe und deren Verwendung für die Gentherapie
JP2002524468A (ja) プロサポシン受容体活性を刺激する方法
WO2025125692A1 (en) Viral vector for transduction of adipocytes
TWI309570B (cg-RX-API-DMAC10.html)
KR19990072793A (ko) Dna서열의유전자수송을위한아데노바이러스전달벡터
JPH11513891A (ja) 細胞系